Boehringer To Acquire Trutino Under Aggressive Cancer R&D Strategy
Remains Mum On Numbers
The family-owned German firm plans to purchase all shares of current partner, Trutino, to gain its systematically delivered cytokine portfolio amid a broader push to diversify and improve its oncology offering.
